I could not really understand all the science in the article...but I did understand this part...
"With very important data coming in the next 3-4 months, we believe Neurocrine shares, already attractively valued based on elagolix, could have another nice leg-up if NBI-98854 succeeds."
All things regress to the mean...it's not if but when.
Margin buying very high, Fed pumping money in, non stop new highs...
When the market turns it will be unpleasant...stop loss orders will trigger more selling...average Joe investor will get whiplash looking around saying "whahapenned"..the big boys will take their marbles and go home for a while...not a question of if but when. Just MHO.
I see your new high from 3/31 and raise you a new high today. Not sure what's going on (other than NBIX getting noticed for a pipeline full of drugs in trials) but I likey.
The Dow Jones/ S&P 500 will not go up every day people. With competitive headwinds blowing in AAPL's face, what is going to happen to the PPS when the market regresses to it's mean, which it ALWAYS ALWAYS ALWAYS does. If you are long you should protect with some out of the money puts in case Captain Cook can't the 'Jobs' done. Short term I think we see 399 before we see 450. JMHO.
Market still has not made a real move south. When it does it will test it's lows.
AAPL will retest 419 low with the coming market pullback...
Even a trains stops.